Afshin Moradi on TSH Level and Stroke Severity
Afshin Moradi, Student and Researcher at Tabriz University of Medical Sciences, shared on LinkedIn:
”I’m pleased to share our recently published study exploring the relationship between thyroid-stimulating hormone (TSH) levels and stroke severity.
Key highlights:
• Stroke severity showed a significant inverse correlation with TSH levels during hospital admission and at discharge.
• Higher TSH levels were associated with less severe stroke symptoms in the acute phase.
• No significant association was found between TSH levels and stroke severity before admission or three months after discharge.
• TSH levels were not related to age, gender, stroke subtype, or CT findings.
These findings suggest a potential role of thyroid function in stroke severity, highlighting the need for further large-scale studies.”
Read the full article here.
Article: Association Between TSH Level and Stroke Severity: A Cross-Sectional Study Using the mRS
Authors: Afshin Moradi, Asal Ebrahimian, Seyed Ardalan Alhoseini, Kosar Baghernezhad, Amir Ghaffarzad, Sona Abolhasani, Vahideh Sadra, Samad Shams Vahdati
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 9, 2026, 15:10Christoffer Gebhardt: Can Anticoagulation Improve Outcomes in Melanoma Therapy?
-
Apr 9, 2026, 15:09National Institutes of Health Addresses VTE Research Funding Gap – JTH
-
Apr 9, 2026, 15:08Alice Assinger: Recruiting PhD Students for NET-IT Doctoral Program in Vienna
-
Apr 9, 2026, 15:07Hannah Cohen: A Novel Approach to Post-Stroke Gait Rehabilitation
-
Apr 9, 2026, 15:07Shehab Mohamed: A Single-Center Experience on Stroke Risk in Polycythemia Vera
-
Apr 9, 2026, 15:06Catch the Brand-New Recap of the Phase III OCEANIC-STROKE Trial – ISTH
-
Apr 9, 2026, 15:06Neeraj Jain: Building Capacity for Better Haemoglobinopathy Care in Maharashtra
-
Apr 9, 2026, 15:05Esther Nakkazi: Armenia Leads WHO Resolution to Advance Haemophilia Care Worldwide
-
Apr 9, 2026, 15:04Quintijn Bonnez: Detecting ADAMTS13 Structural Changes with Conformation-Sensitive Antibody 1C4